World-leading Australian science: 17M protein structures added to the AlphaFold Database to accelerate the fight against antimicrobial resistance

Australian researcher, George Bouras, has recently contributed an extraordinary 17 million protein predictions to an international open access database. The availability of the large-scale dataset in the AlphaFold Protein Structure Database will have a transformative impact on the international fight to combat antimicrobial resistance. 

As the lead of the AllTheBacteria protein structure prediction project, the Adelaide University bioinformatician and current PhD student completed his world-leading work using resources made available through a BioCommons partnership with Pawsey Supercomputing Research Centre. George’s work became possible only when the right human and compute resources came together. Working closely with BioCommons, Pawsey’s Dr Sarah Beecroft containerised the ColabFold tool for use on Setonix's AMD GPUs. Once ColabFold was ported and stable, George could utilise the massive scale of Pawsey’s Setonix to create the 17 million structural predictions for bacterial proteins. 

Source image: AlphaFold prediction of a banna virus spike protein VP4 (AF-0000000365762994-v1). Design credit: Karen Arnott/ EMBL-EBI.

George was honoured to contribute to the AlphaFold Database, one of several high-value datasets for microbial and viral proteins selected from specialist communities. This integration of essential, high-quality datasets from users reinforces the AlphaFold Database’s role as an inclusive, and community-driven resource. The database provides open access to over 200 million protein structure predictions, and the developers,Google DeepMind and EMBL’s European Bioinformatics Institute (EMBL-EBI), are wanting to expand their impact for specialist areas including pandemic preparedness, antimicrobial resistance, neglected tropical diseases and environmental sciences.  

“I hope that access to these novel bacterial protein structures derived from high-quality genome assemblies will lead to better understanding of the function of all bacterial proteins.” – George Bouras, lead of the AllTheBacteria

The availability of the ColabFold container for use on Setonix’s AMD GPUs also allowed George to generate more than 3 million phage and viral structures, which are now used for protein structure-informed bacteriophage genome annotation hundreds of thousands of times each day by researchers around the world. 

This example shows how close working relationships with both researchers and the Tier-1 HPC infrastructures enables BioCommons to precisely respond to community needs and accelerate Australian science at a scale. Making valuable tools accessible on national platforms is a focus of the BioCommons BioCLI project, and this work paves the way for the creation of a new national protein folding service further streamlining the use of Pawsey computing resources.

A publication about this work is currently under peer review, but in the meantime you can read the release from EBI.

GlyCombo: the first dedicated glycomics workflow on Galaxy

In a win for the international glycomics community, the first dedicated glycomics and carbohydrate software tool is available on the global Galaxy platform thanks to a group of Australian researchers. GlyCombo, a high-throughput tool for glycan (sugar polymers present in protein samples) identification is now providing glycomics researchers with a streamlined, reproducible way to process their complex mass spectrometry (MS) data within Galaxy Australia. The workflow that performs a conversion of raw files, GlyCombo search, and visualisation of results glycan and polysaccharide compositions from mass spectrometry files has been shared through the publication on the GlyCombo Galaxy workflow on WorkflowHub.

The availability of this tool and workflow is the result of collaboration between the Galaxy Australia team and Protea Glycosciences, an innovative Australian glycosciences company based in Wollongong.

Dr Chris Ashwood and Dr Maia Kelly, Protea Glycosciences

By wrapping their open-source GlyCombo tool for Galaxy, Protea Glycosciences has made state-of-the-art analytical techniques accessible to researchers worldwide with just a few clicks.

How GlyCombo simplifies glycomics analysis

Rapid identification of glycans present in MS samples is a cornerstone of glycomics research and is integral to robust glycomics analysis pipelines, yet glycomics research is often limited by a lack of throughput and reproducible data analysis to enable subsequent structural elucidation. Protea Glycosciences was established in 2023 to address this gap, bringing a structure-oriented approach.

While traditional web-based tools utilise point-and-click interactions, GlyCombo enables researchers to rapidly process large-scale, complex MS datasets with greater efficiency and reproducibility. Through text-based commands, glycomics researchers can automate the assignment of monosaccharide combinations, handle multiple adduct searches, and anticipate off-by-one errors, while simultaneously maintaining detailed records of their analytical workflows. 

The Galaxy GlyCombo workflow successfully monitored the glycomic consequences of biotransformation, detecting the drastic compositional shifts resulting from sialidase treatment directly within a fully reproducible, browser-based workflow.

Bringing the tool to Galaxy Australia

Protea Glycosciences have wrapped their open source tool for the platform, and the Galaxy Australia team have provided technical support to enable this easy access to the software. The integration of GlyCombo onto Galaxy Australia is a prime example of how national research infrastructure supports the Australian life sciences ecosystem, and how BioCommons and Galaxy Australia support industry-based Research and Development. Hundreds of researchers from Australian small-to-medium enterprises (SMEs) and startups use these subsidised services and the generous computational and working data storage quotas to accelerate their work.

“We built GlyCombo as an open-source tool to solve an analytical challenge, but software is only useful if people can run it. Galaxy makes complex workflows reproducible and accessible without local infrastructure or programming expertise. Partnering with Galaxy Australia was a direct path to putting rigorously tested glycomics workflows in front of researchers who need it and lowers the barrier to entry for the broader glycomics community.” - Dr Chris Ashwood, Director, Protea Glycosciences.

Learn more

• Check out the GlyCombo software tool on Galaxy Australia

• Access the Galaxy workflow on WorkflowHub

• Read the paper: GlyComboCLI enables command line-based FAIR workflows for glycan composition assignment in mass spectrometry data

Global collaboration advancing AI and biomedical data infrastructure

As part of a week-long international engagement program, BioCommons brought together research data infrastructure experts from the USA, Finland, New Zealand and across Australia. The Human Genome Informatics division at BioCommons hosted Prof Robert Grossman, University of Chicago, the founder and lead of the Gen3 platform, to strengthen the collaborative and technical capability required to build world-class human genomics and biomedical data infrastructure in Australia.

Participants engaged in a series of strategic discussions and technical demonstrations focused on solving the complex challenges of data commons development, federated data access, security and governance frameworks, and international interoperability initiatives. 

Reflecting on the growing importance of research data infrastructure, Prof Matthew Watt, Associate Dean Research at the University of Melbourne’s Faculty of Medicine, Dentistry and Health Sciences, noted that ‘well-designed data ecosystems are no longer optional - they are foundational infrastructure for modern biomedical discovery.’

Prof Robert Grossman presenting during his seminar at the University of Melbourne

A particular highlight of the week was a seminar, ‘In Praise of Midscale Language Models and AI Commons and Their Applications to Biology, Medicine and Healthcare’, which sparked significant interest in how secure infrastructure can support the next generation of AI-driven biomedical research.

The discussions highlighted the value of strong international collaboration in advancing secure, scalable, and interoperable approaches to genomics and health data sharing, while also strengthening relationships across the global research infrastructure community. Participants noted the high quality of strategic conversations, which not only strengthened relationships but also reaffirmed Australia’s position as a leader in deploying these sophisticated systems.

How is Gen3 utilised in Australian human genomics research?

The Gen3 platform provides a robust framework to receive, manage, and describe massive datasets, allowing them to be shared securely with authorised users. It is the technology behind numerous US National Institutes of Health (NIH) projects that house data from hundreds of thousands of samples.

BioCommons has successfully led the implementation of Gen3 platforms for several landmark national projects, demonstrating our capability to adapt global best practices for the Australian research landscape. These include:

• OMIX3: Led by the University of Melbourne, OMIX3 utilises mass spectrometry to enable the parallel collection of proteomics, metabolomics and lipidomics data, and is the first successful implementation of a Gen3 platform outside of the USA.

• Australian Cardiovascular disease Data Commons (ACDC): Led by the Baker Heart and Diabetes Institute, ACDC provides a secure, Gen3-powered infrastructure to pool data from 400,000 individuals across 18 clinical cohorts. 

• Biological Psychiatry Data Commons (BPsych-DC): Led by the Consortium for Preclinical Psychiatric Research, providing a national digital infrastructure to harmonise multi-omics data across cellular, animal and human psychiatric models, bridging the gap between discovery and clinical impact

Prof Bernard Pope, GUARDIANS Program Lead and A/Director (Human Genome Informatics) at BioCommons, reflected on the highlights of the week: 

‘Data commons are the backbone of collaborative genomic research. The ability to securely connect, govern, and analyse large-scale datasets is increasingly critical for translating research discoveries into meaningful health and clinical impact.’

‘The success of projects like OMIX3 and ACDC is built on years of shared expertise between our team and the architects of Gen3. By hosting international experts through the GUARDIANS program, we are ensuring that Australian researchers have access to the same secure, scalable technologies that power the world’s largest genomic projects.’

Take a closer look at the GUARDIANS Program: https://www.biocommons.org.au/guardians

Research communities can build their own digital labs with Australian innovation: Galaxy Labs Engine

The Galaxy Labs Engine has been described in a new paper, including how it supports the easy creation of tailored research environments. Several domain-specific portals have now been generated on Galaxy Australia that guide researchers through curated and globally synchronised bioinformatics analysis resources

The Galaxy Labs Engine (GLE) allows research communities to build and synchronise their own Galaxy Labs, which guide users through curated tools, workflows, and training resources. These bespoke interfaces are especially helpful for researchers who are new to the analytical methods or technologies specific to the domain. 

Galaxy Labs are an extension of the established feature of ‘Galaxy Flavours’, subdomains which offer curated content for specific research domains. However, these subdomains have been limited by having static deployments, being difficult to replicate across servers, and often provide inconsistent user interfaces. By separating the content from technical deployment, the engine allows research communities to build custom Labs that stay synchronised with global resources through GitHub.

Development of the GLE service was led by the Galaxy Australia team, originating from a project at the ‘Aussie Outpost’ of the ELIXIR BioHackathon Europe, hosted by Australian BioCommons in 2022. 

The GLE has been used on the Galaxy Australia server to build the Microbiology and Single cell Labs, with the eDNA Lab currently being built, joining the Genome and Proteomics Labs as part of the expanding list of pre-configured Labs available. The engine is already being employed abroad by Galaxy France for their Ecology Lab, and to encourage global collaboration all Lab content is hosted in the Galaxy Project’s Codex GitHub repository. 

Reflecting on how the team is always developing new ways to empower researchers, Galaxy Australia Product Owner Dr Gareth Price noted:

‘Our goal was to make constructing a Galaxy Lab an easy and accessible process for the whole community. Our team is already looking ahead as we finalise the deployment of an AI-assisted Lab builder, again reducing the technical barriers for researchers to start on their own Lab journey.’

You can read the paper in Gigascience

Explore the Galaxy Labs on the BioCommons website

Read Dr Gareth Price’s blog post on Galaxy News

Collaborating globally to develop a foundational structural biology training module

An international joint effort spanning the course of a year has produced a cutting-edge self-paced training resource in structural biology. The Foundations of protein structure module was developed by the Australian Structural Biology Computing (ASBC) community, the European Molecular Biology Laboratory European Bioinformatics Institute’s (EMBL-EBI) Protein Data Bank in Europe, and BioCommons, with the aim of providing accessible training for researchers who want to understand and use protein structures in their work.

‘Alignment, adoption and contribution to global best-practice efforts’ were aims of the Australian Structural Biology Deep-Learning Infrastructure Roadmap, developed in partnership between the ASBC and BioCommons in 2025. By co-designing this module with our partners at EMBL-EBI, we are excited to contribute to the resources they provide to an international audience of researchers.

What is the module and how does it benefit researchers?

Many researchers, undergraduates and clinicians want to use protein structures in their work, but don’t necessarily have the prerequisite knowledge to bridge the gap between theory and practice. This module onboards researchers to the domain, by providing an understanding of the fundamental concepts of protein structural biology, including protein composition, folding, architecture, dynamics, and interactions.

Protein structure elements (Image: EMBL-EBI Training)

For example learners gain insight into:

• The sequence-structure-function relationship

• Secondary, tertiary and quaternary structures, including alpha helixes and beta sheets, motifs, domains, and folds

• The dynamic and flexible nature of proteins and how this impacts biological function.

Who developed ‘Foundations of structural biology’?

The module was co-designed over twelve months by collaborators based across Australia and the United Kingdom. As the team was working across continents and vast time zones, they relied on a mix of asynchronous drafting and regular online meetings for coordination, planning, and discussion of the content.

The contributors were:

• From the ASBC and BioCommons: Dr Michael Healy (University of Queensland), Dr Kristina Gagalova (Curtin University), Dr Kate Michie (UNSW), Dr Thomas Litfin (UNSW and Australian BioCommons), and Dr Johan Gustafsson (Australian BioCommons)

• From EMBL-EBI: Dr Jennifer Fleming, Dr Paulyna Magaña, Dr Flaminia Zane (reviewer), and Dr Ajay Mishra (reviewer).

Beyond the module itself, this project has strengthened the connection between EMBL-EBI, the ASBC, and BioCommons, and will lead to further collaboration on a set of structural bioinformatics modules that will complement and extend existing EMBL-EBI training resources.

Foundations of protein structure has been released as an online tutorial by EMBL-EBI Training as part of their mission to deliver world-class training in data-driven life sciences.

Global genomic data sharing enabled by purpose-built platform

A new secure data sharing platform, called SeqHaven, is facilitating the transfer of large volumes of human genomics research data in Australia. Delivered by the QIMR Berghofer Genome Informatics and Medical Genomics teams as part of the GUARDIANS program of work, the new service has streamlined the way massive genomic datasets are shared.

What does the data sharing platform do?

The platform is a dedicated, scalable system that provides an environment for safely and efficiently transferring large volumes of genomic data generated by QIMR Berghofer's researchers. Significantly, it recently shared the first major dataset using technology built for GUARDIANS, and will go on to underpin the sharing of resources such as the International Cancer Genome Consortium’s (ICGC) datasets on melanoma and pancreatic cancers. 

The tailored infrastructure is helping to relieve a technical bottleneck in collaborative research, which has enabled QIMR Berghofer to share data with collaborators in Australia and globally. As with all components of the national GUARDIANS project, strict privacy and confidentiality requirements have been a priority. Access and data governance are supported by the QIMR Berghofer Data Access Committee, who ensure responsible transfer of genomic data that always respects the wishes of research participants.

The platform uses Globus to securely transfer large files between research organisations in Australia and overseas, enabling genomic research data to be made available to verified researchers via controlled access. This demonstration of a scalable solution to a common challenge used AARNet’s Globus service to share large-scale data across organisational boundaries and international borders.

How will this impact researchers?

The ability to move large volumes of data without compromising security is an integral requirement for genomics. Increased data sharing improves statistical power, supports new insights from existing datasets, and promotes collaboration across institutions to accelerate discovery and improve health outcomes. The new platform allows researchers to leverage valuable datasets, with data custodians being confident that rigorous data governance policies are in place.

‘The SeqHaven platform is a game-changer in how we, as researchers, manage collaborations and data sharing,’ says John Pearson, Project Lead at QIMR Berghofer. ‘It allows us to move big data while protecting our systems and, ultimately, our participants.’

This sentiment is echoed by BioCommons A/Director (Human Genome Informatics) and GUARDIANS program lead, Prof Bernie Pope:

‘This national collaboration is a prime example of how the GUARDIANS program is uplifting our national research infrastructure to help researchers easily discover, access and analyse human genomics research data.’’

Learn more

QIMR Berghofer welcomes further enquiries from the Australian genomics community about sharing their data by contacting the QIMR Berghofer Data Access Committee.

You can hear more from John Pearson, Manager, Genome Informatics Group, QIMR Berghofer Medical Research Institute, about the development of the SeqHaven platform and the integration of Globus software, along with other life science applications in the upcoming BioCommons webinar: Globus: moving large volumes of research data with ease.

Key molecular structure prediction datasets now available in the new Structural Biology AI Reference Collection

The prediction and analysis of protein structure by Australian researchers has been accelerated by the publication of the Structural Biology AI Reference Collection at the National Computational Infrastructure (NCI). This collection includes key datasets required to support deep learning models for molecular structure prediction. Its creation is a result of a targeted collaboration between Australian BioCommons, UNSW Sydney and NCI staff.

How does this new resource help researchers?

The Structural Biology AI Reference Collection includes several replicated datasets required to support protein structure research, including various deep learning models for molecular structure prediction. These copies of sequence and structure databases include UniProt, MGnify and the PDB will be regularly updated, providing a citable, versioned resource and ensuring reproducible research. The datasets support higher quality model predictions using tools such as AlphaFold3, AlphaFold2, Boltz, RoseTTaFold-All-Atom and HelixFold3.

3D molecular visualisations showing the complex structural interactions between proteins and DNA (Image: Science Photo Library)

Created through national collaboration

A team from UNSW comprising Dr Tom Litfin (Australian BioCommons) and Joshua Caley (Structural Biology Facility) worked directly with the NCI Data Collections team to add the new resources to the NCI Data Catalogue. NCI is an important partner in the BioCommons BioCLI and Workflow Commons projects, and this data collection is an example of our shared ambitions to streamline processing and analysis of molecular data at scale, and establish national ecosystems that support life science researchers at the community level.

How can researchers access the data?

The Structural Biology AI Reference Collection is now freely available. Existing NCI users can register for file-system access through the MyNCI User Portal. New users should review the information on the data products, licences, and data access to get started. 

The Structural Biology AI Reference Collection is supported by the Australian Structural Biology Computing community, Australian BioCommons, and the UNSW Structural Biology Facility.

Meet the Team: Mok, UX Designer

Describe your role at BioCommons

I’m a user experience (UX) Designer at BioCommons, which means that I help improve infrastructure and scientific research by being the friendly translator between complex systems and real humans. This type of role is new in the life sciences field, making it a lot of fun, as I sit at the intersection of science, data, and human-centred design, helping researchers, bioinformaticians, and software engineers make sense of the inherently complex biological tools and platforms they use everyday.  The goal is to make it look easy - even when it’s not!

It’s challenging work, because the problems are big and complex. You’re designing for expert users, emerging technologies, and systems that genuinely matter.

There’s a lot to learn, a lot to ask, and plenty of moments where curiosity and collaboration are essential. This makes the role deeply rewarding, as your work doesn’t just improve usability; it helps accelerate research, supports discovery, and amplifies the impact of national life-science infrastructure.

How can UX Designers improve infrastructure and/or scientific research?

Think of scientific infrastructure as a powerful machine: data platforms, tools, pipelines, and services that can do amazing things. A UX Designer ensures that people can actually use that power without needing a PhD in ‘figuring stuff out’. 

By taking complicated processes and reshaping them into smooth, logical journeys, we turn confusion into clarity. This saves researchers time and frustration - when tools are intuitive, scientists spend less time wrestling with interfaces and more time doing what they love: discovering, analysing, and innovating.

Good UX also makes infrastructure more accessible. It opens the door for students and early-career researchers to use advanced systems confidently, rather than those tools being limited to the experts that already know the ropes. By asking the right questions early and understanding user needs upfront, we help teams build the right thing the first time. This reduces rework and ensures that research workflows flow smoothly, helping insights travel from idea to impact more quickly.

What is the real-world impact of human-centred design at BioCommons?

At BioCommons, my impact is all about making powerful research infrastructure feel simple, friendly, and usable. I focus on turning complex scientific tools into clear experiences, helping researchers spend less time navigating systems and more time doing great science. 

By listening to users and smoothing out workflows, I help ensure that BioCommons tools are not just functional, but adopted and used to their full potential. In short: I make hard things easier, science faster, and national infrastructure more human.

What makes solving scientific problems so rewarding?

This is not your average UX gig, and that’s exactly the point. I get to work closely with scientists, engineers, product leads, and stakeholders who are passionate about what they do and who will happily stretch my thinking.

It is incredibly rewarding to work in a space where UX isn’t just ‘nice to have’, but genuinely transformative. There is a unique joy in those moments where a complex process suddenly becomes clear and usable.

In short: it’s a role for UX designers who like their work meaningful, their challenges meaty, and their wins shared with science itself!

View Mok’s profile on the BioCommons website

Strengthening Australia’s Nextflow community through local and global collaboration

The Australian satellite site of the 2026 nf-core Hackathon has just taken place at the BioCommons node at Sydney Informatics Hub, the University of Sydney. The hands-on event brought together members of Australia’s  Nextflow and nf-core community to contribute to nf-core projects, while strengthening connections locally and across the global community.

Twelve participants from University of NSW, University of Sydney, and University of Melbourne came together to collaborate in person on cutting-edge nf-core projects, with support from two Nextflow Ambassadors on BioCommons’ team, Dr Georgie Samaha and Dr Ziad Al Bkhetan.

As one of 29 global hackathon sites, the Australian team contributed to the international nf-core effort through asynchronous collaboration. Given our geography, the team was among the first to kick off the work, closing each day by connecting with the APAC teams working from sites in Aotearoa New Zealand and South Korea.

Attendees at the satellite site at the Sydney Informatics Hub, University of Sydney

The group made meaningful contributions to several nf-core projects, working to: close open issues and make a release for the nf-core ProteinFold pipeline; develop a new ConfigBuilder tool in the nf-core tools suite that helps users build Nextflow configuration files; and edit Nextflow for HPC training materials to support implementation by others with new documentation for trainers.

It was wonderful to see the progress made by the productive participants over three days together, and the outcomes reflect the depth of expertise and collaborative spirit of the Australian community. We are grateful to all participants for the energy and enthusiasm they brought. Thanks also to the Seqera team and the nf-core community for their support for the Australian satellite site of the hackathon, and especially for sponsoring our delicious lunch together on the final day!

Want to learn how to run and customise nf-core workflows? The Unlocking nf-core: customising workflows for your research workshop is taking applications now, and registrations are also open for our upcoming webinar Using Containers in Nextflow.

AI for Science Hackathon connects industry with research to accelerate Australian science

The AI for Science Australian Hackathon recently wrapped up in Melbourne, bringing together researchers and technical experts to port, accelerate and optimise research applications. The week-long event paired a select group of research projects with computational mentors and powerful compute tailored to their needs. Organised in collaboration with NVIDIA and OpenACC and hosted at Monash University, BioCommons also joined Pawsey Supercomputing Research Centre, National Computational Infrastructure and SHARON AI to boost projects across structural biology, advanced engineering, quantum chemistry and climate modelling.

What life science challenges were tackled?

Several teams leveraged the opportunity to translate software and hardware optimisations to existing medical and human health challenges. A key factor for teams applying to the event was to bring a mature project that could utilise the available mentorship and compute resources effectively.

Attendees, organisers and mentors of the hackathon

A group from the Australian Structural Biology Computing (ASBC) community brought interdisciplinary expertise from UNSW’s Structural Biology Facility, WEHI, and the Monash AI Protein Design Program to optimise protein structure prediction and design workflows. The project incorporated GPU-enabled MMSeqs2 for accelerated sequence search and improved throughput and memory use of the Boltz-2 implementation for structure prediction. This work has been contributed to community-maintained Nextflow nf-core pipelines to promote efficient workflows for researchers worldwide.

A joint Australian Centre for Artificial Intelligence in Medical Innovation (La Trobe University) and Florey Institute of Neuroscience and Mental Health team tackled a highly complex 20,000-line codebase dedicated to childhood dementia research. Their project focused on predicting whether mRNA sequence data could accurately target the specific NPC1 mutation responsible for the disease. BioCommons’ AI Technical Lead, Dr Benjamin Goudey supported this work as a dedicated mentor. By bridging the gap between the hardware experts and the life science researchers, Ben helped the team navigate their massive codebase to ensure their mRNA dementia research workflows could run efficiently on the accelerated GPUs.

What technical outcomes were achieved?

By exploring batched inference strategies,  some workloads in the structural biology project saw a four-fold speed increase, alleviating major predictive bottlenecks in high value protein design workflows. The team also doubled their maximum prediction size by chunking operations at key memory bottlenecks and working around overflow bugs in high-level libraries like PyTorch and trifast. With access to impressive hardware in the form of eight NVIDIA B200 GPUs, participating teams achieved substantial performance gains as well as insights into maximising the benefit of GPU acceleration within their research.

The event was a major upskilling opportunity, with researchers experimenting with agentic coding, getting introduced to GPU-accelerated data processing libraries (NVIDIA RAPIDS), and working under the guidance of expert mentors to iterate their optimisations.

Reflecting on the event, Dr Thomas Litfin, a UNSW researcher supported by Australian BioCommons and member of the ASBC community, highlighted the immense value of this hands-on support, as well as the lasting impact of the connections forged during the week:

‘The groups got an incredible amount of value from the expert mentors, who were instrumental in suggesting strategies and troubleshooting bottlenecks on the fly. The event was also a great community building exercise for our project by bringing together people from Monash, WEHI, and UNSW, and creating opportunities for ongoing collaborations.’

As AI methodologies become increasingly embedded in the life sciences, BioCommons will continue working alongside our partners to ensure researchers have both the cutting-edge digital infrastructure and the specialised skills needed to use it.

• Read more about the event in the blog post by host Monash University.

• Hear what the National AI Survey told BioCommons about researchers’ AI needs in the Future of AI in Life Sciences webinar.